-
CNTA Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Centessa Pharmaceuticals (CNTA)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | |
---|---|---|---|---|
Revenue | ||||
Cost of revenue | ||||
Operating income | ||||
Operating margin | ||||
Net income | ||||
Net profit margin | ||||
Cash on hand | ||||
Change in cash | ||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 395.03 mm | 395.03 mm | 395.03 mm | 395.03 mm | 395.03 mm | 395.03 mm |
Cash burn (monthly) | (no burn) | (no burn) | 15.47 mm | 13.64 mm | 7.13 mm | 10.86 mm |
Cash used (since last report) | n/a | n/a | 62.22 mm | 54.85 mm | 28.68 mm | 43.68 mm |
Cash remaining | n/a | n/a | 332.81 mm | 340.17 mm | 366.35 mm | 351.35 mm |
Runway (months of cash) | n/a | n/a | 21.5 | 24.9 | 51.4 | 32.4 |
13F holders | Current |
---|---|
Total holders | 106 |
Opened positions | 32 |
Closed positions | 10 |
Increased positions | 44 |
Reduced positions | 16 |
13F shares | Current |
---|---|
Total value | 1.60 tn |
Total shares | 148.18 mm |
Total puts | 53.00 k |
Total calls | 5.90 k |
Total put/call ratio | 9.0 |
Largest owners | Shares | Value |
---|---|---|
Medicxi Growth I | 19.96 mm | $0.00 |
Medicxi Ventures Management | 19.96 mm | $319.21 bn |
Index Ventures Life Vi | 9.96 mm | $112.17 mm |
General Atlantic | 9.68 mm | $154.81 bn |
Atlantic Cooperatief U.A. General | 9.68 mm | $243.11 mm |
Perceptive Advisors | 6.28 mm | $100.45 bn |
First Light Asset Management | 5.94 mm | $94.98 bn |
T. Rowe Price | 4.68 mm | $74.82 mm |
Adage Capital Partners GP, L.L.C. | 4.20 mm | $67.08 bn |
Vida Ventures Advisors | 3.93 mm | $62.87 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
27 Jan 25 | Gregory M Weinhoff | Ordinary Shares | Sell | Dispose S | No | Yes | 16.4733 | 11,742 | 193.43 k | 159,782 |
21 Jan 25 | Saurabh Saha | Ordinary Shares | Sell | Dispose S | No | Yes | 16.1937 | 1,625 | 26.31 k | 429,398 |
21 Jan 25 | Saurabh Saha | Ordinary Shares | Sell | Dispose S | No | Yes | 15.7586 | 53,375 | 841.12 k | 431,023 |
15 Jan 25 | Iqbal J Hussain | Ordinary Shares | Sell | Dispose S | No | Yes | 15.29 | 6,000 | 91.74 k | 118,265 |
15 Jan 25 | Iqbal J Hussain | Ordinary Shares | Option exercise | Acquire M | No | No | 5.84 | 6,000 | 35.04 k | 124,265 |
15 Jan 25 | Iqbal J Hussain | Share Option Ordinary Shares | Option exercise | Dispose M | No | No | 5.84 | 6,000 | 35.04 k | 321,559 |
31 Dec 24 | Saurabh Saha | Ordinary Shares | Payment of exercise | Dispose F | No | No | 16.35 | 36,263 | 592.90 k | 484,398 |